Can-Fite Biopharma Ltd American Depositary Shares each representing two (2) (CANF) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Can-Fite Biopharma Ltd American Depositary Shares each representing two (2) (CANF) is Moderate Underperform.

The composite score behind that read is -0.33, weighing +0.00 of bullish evidence against -0.50 bearish.

Can-Fite Biopharma Ltd American Depositary Shares each representing two (2) last closed at $1.90, -5.00% on the session.

Against the IVW growth benchmark the position is -5.80% over the forecast window.

The read is built from 15 underlying insights — 0 bullish and 15 bearish.

Agreement across those insights is 100%.

20 graded predictions for CANF so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

Can-Fite Biopharma Ltd American Depositary Shares each representing two (2) is classified under Health Care / Biotechnology, with a market capitalisation of $6.06M.

StockMap tracks Can-Fite Biopharma Ltd American Depositary Shares each representing two (2) as the 368th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Can-Fite Biopharma Ltd American Depositary Shares each representing two (2) ranks 371st of 381 in the group, against a group median of -0.08.